JIM
IONS icon

Jupiter Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Jupiter Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.02M Sell
17,294
-1,190
-6% -$66.2K 0.02% 284
2020
Q1 		$873K Hold
18,484
– – 0.02% 255
2019
Q4 		$1.12M Buy
+18,484
New +$1.1M 0.02% 315

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Jupiter Investment Management's IONS Position: Q2 2020 in Review

Jupiter Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 6.4% in Q2 2020, selling an estimated $66.2K and leaving 17,294 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #284.

Jupiter Investment Management first reported a position in IONS in Q4 2019 and has held it in 3 quarters since. The position peaked at $1.12M in Q4 2019. 375 funds tracked by Wall St. Rank hold IONS as of Q2 2020.

  • Jupiter Investment Management held 17,294 shares of Ionis Pharmaceuticals worth $1.02M as of Q2 2020.
  • Jupiter Investment Management sold 1,190 Ionis Pharmaceuticals shares in Q2 2020, an estimated $66.2K.
  • Ionis Pharmaceuticals made up 0.02% of Jupiter Investment Management's portfolio in Q2 2020, its #284 holding.
  • Jupiter Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 3 quarters since.
  • Jupiter Investment Management's Ionis Pharmaceuticals position peaked at $1.12M in Q4 2019.
  • 375 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.